Literature DB >> 2302103

Five-year follow-up of helium ion therapy for uveal melanoma.

D H Char1, J R Castro, S M Kroll, A R Irvine, J M Quivey, R D Stone.   

Abstract

One hundred sixty-four patients with uveal melanoma were treated with helium ion irradiation prior to May 1984, and the data were analyzed in June 1989. Most uveal melanomas were large, with a mean tumor thickness of 6.5 mm; approximately 60% of the patients had tumors that extended anterior to the equator. A complete follow-up was obtained for all patients. One hundred twelve patients were alive at the time of this report; 18% of the patients developed clinical and laboratory evidence of metastases and eventually died of widespread tumor. Eighty-four percent of eyes were retained. Data were analyzed with a number of parametric and nonparametric techniques. Larger tumors and those located in close proximity to the optic nerve and fovea had a higher incidence of most complications, especially visual loss.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2302103     DOI: 10.1001/archopht.1990.01070040061031

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  13 in total

Review 1.  Uveal melanoma: therapeutic consequences of doubling times and irradiation results; a review.

Authors:  W A Manschot; R van Strik
Journal:  Int Ophthalmol       Date:  1992-03       Impact factor: 2.031

2.  Proton therapy for uveal melanomas and other eye lesions.

Authors:  J E Munzenrider
Journal:  Strahlenther Onkol       Date:  1999-06       Impact factor: 3.621

3.  Concurrent versus sequential application of ferromagnetic hyperthermia and 125I brachytherapy of melanoma in an animal model.

Authors:  W F Mieler
Journal:  Trans Am Ophthalmol Soc       Date:  1997

4.  Long-term follow-up after uveal melanoma charged particle therapy.

Authors:  D H Char; S M Kroll; J Castro
Journal:  Trans Am Ophthalmol Soc       Date:  1997

5.  Development and validation of a patient based measure of outcome in ocular melanoma.

Authors:  A J Foss; D L Lamping; S Schroter; J Hungerford
Journal:  Br J Ophthalmol       Date:  2000-04       Impact factor: 4.638

6.  Intraocular inflammation after proton beam irradiation for uveal melanoma.

Authors:  L Lumbroso; L Desjardins; C Levy; C Plancher; E Frau; F D'Hermies; P Schlienger; H Mammar; S Delacroix; C Nauraye; R Ferrand; C Desblancs; A Mazal; B Asselain
Journal:  Br J Ophthalmol       Date:  2001-11       Impact factor: 4.638

7.  Long term visual outcome of radiated uveal melanomas in eyes eligible for randomisation to enucleation versus brachytherapy.

Authors:  D H Char; S Kroll; J M Quivey; J Castro
Journal:  Br J Ophthalmol       Date:  1996-02       Impact factor: 4.638

8.  Risk factors for metastatic uveal melanoma after trans-scleral local resection.

Authors:  B E Damato; J Paul; W S Foulds
Journal:  Br J Ophthalmol       Date:  1996-02       Impact factor: 4.638

9.  Radiation-induced optic neuropathy following brachytherapy of uveal melanomas.

Authors:  U Kellner; N Bornfeld; M H Foerster
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1993-05       Impact factor: 3.117

10.  Gamma-knife-based stereotactic radiosurgery for medium- and large-sized posterior uveal melanoma.

Authors:  Ahmet M Sarici; Halit Pazarli
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-09-04       Impact factor: 3.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.